Biology of Blood and Marrow Transplantation
Volume 15, Issue 5 , Pages 574-579 , May 2009

A Comparison of Measured Creatinine Clearance versus Calculated Glomerular Filtration Rate for Assessment of Renal Function before Autologous and Allogeneic BMT

Received 4 November 2008 ,Accepted 22 January 2009.

References 

  1. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int. 1994;46:1443–1458
  2. Gruss E, Bernis C, Tomas JF, et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol. 1995;15:473–479
  3. Miralbell R, Bieri S, Mermillod B, et al. Chapuis B. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol. 1996;14:579–585
  4. Foninck E, Cahn JY. Renal toxicity after bone marrow transplantation. Int J Radiat Oncol Biol Phys. 2004;58:661–662
  5. The Kidney Disease Outcome Quality Initiative . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl. 1):S1–S246
  6. Peters AM. Quantification of renal haemodynamics with radionucleotides. Eur J Nucl Med. 1991;18:274–286
  7. Rehling M, Moller ML, Lund JO, et al. Simultaneous measurement of Tc-99mDTPA, Cr-51 EDTA and inulin in man. Clin Sci. 1984;66:613–619
  8. Holweger K, Bokemeyer C, Lipp HP. Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge. J Cancer Res Clin Oncol. 2005;131:559–567
  9. Jacobson P, West N, Hutchinson RJ. Predictive ability of creatinine clearance estimate models in pediatric bone marrow transplant patients. Bone Marrow Transplant. 1997;19:481–485
  10. Marx GM, Blake GM, Galani E, et al. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol. 2004;15:291–295
  11. Nagao S, Fujiwara K, Imafuku N, et al. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula. Gyn Oncol. 2005;99:327–333
  12. Poole SG, Dooley MJ, Rischin D. A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients. Ann Oncol. 2002;13:949–955
  13. Raj GV, Iasonos A, Herr H, Donat SM. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. J Clin Oncol. 2006;24:3095–3100
  14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
  16. Jelliffe RW. Creatinine clearance: bedside estimate. Ann Intern Med. 1973;79:604–605
  17. Wright JG, Boddy AV, Highley MS, et al. Estimation of glomerular filtration rate in cancer patients. Br J Cancer. 2001;84:452–459
  18. Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562–1568
  19. van Acker BA, Koomen GC, Koopman MG, et al. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet. 1992;340:1326–1329

 Financial disclosure: See Acknowledgments on page 579.

PII: S1083-8791(09)00060-3

doi: 10.1016/j.bbmt.2009.01.015

Biology of Blood and Marrow Transplantation
Volume 15, Issue 5 , Pages 574-579 , May 2009